For investors in gene therapy biotech bluebird bio, a wait-and-see approach toward a proposed acquisition has paid off. | For ...

Dwayne Rosado and his son spent a day with Kiss star Gene Simmons and talked about sex, (a lack of) drugs and rock'n'roll ...

A baby born with a rare and dangerous genetic disease is thriving after getting an experimental gene editing treatment made ...

Tinkering in a garage created Hewlett Packard 86 years ago, but fraught financial fiddling complicated matters. The ...

Brussels has made an 11th hour gambit to get Britain to halt advanced work on gene editing crops, which would allow UK farmer ...

Spring has been bountiful at Cleveland's Abeona Therapeutics. | As Abeona gears up for the commercial rollout of Zevaskyn, ...

Forge says it will provide Fractyl process development, cGMP manufacturing, and analytical development services.

To better understand deal-making trends related to cell and gene therapies, we conducted an analysis of recent activity in the sector. We reviewed more than 30 mergers, acquisitions, and licensing ...

"This 90-day reprieve is not a long runway," says Port of Los Angeles Executive Director Gene Seroka, as he discusses an uptick in cargo bookings from China in recent days and the procurement ...

A new agtech company focused on enhancing gene editing for plants has launched in St. Louis, the Danforth Technology Company ...

GEN talked with several contract development and manufacturing organizations (CDMOs) and/or contract research organizations (CROs) about new ways they are addressing AAV manufacturing challenges.

Roche’s gene therapy unit Spark has added to its pipeline in inherited retinal diseases (IRDs) with a $216 million alliance with Spanish biotech SpliceBio. Under the terms of the deal ...